PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · IEX Real-Time Price · USD
2.950
-0.080 (-2.64%)
At close: Jul 2, 2024, 4:00 PM
3.000
+0.050 (1.69%)
After-hours: Jul 2, 2024, 6:21 PM EDT
PDS Biotechnology Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for PDS Biotechnology stock have an average target of 16.67, with a low estimate of 9.00 and a high estimate of 21. The average target predicts an increase of 465.08% from the current stock price of 2.95.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PDSB stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 2 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 3 | 3 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +611.86% | Jun 12, 2024 |
B. Riley Securities | B. Riley Securities | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +205.08% | Jun 12, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +611.86% | May 15, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +611.86% | May 9, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 9, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
280.50K
EPS This Year
-1.32
from -1.39
EPS Next Year
-1.26
from -1.32
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | 1.2M | 23.6M | 48.6M | 126.1M |
Avg | n/a | 280,500 | 7.7M | 21.3M | 89.1M |
Low | n/a | n/a | n/a | n/a | 30.0M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | 8,322.5% | 535.5% | 492.5% |
Avg | - | - | 2,627.3% | 178.2% | 318.6% |
Low | - | - | - | - | 41.1% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.17 | -1.02 | -1.10 | -0.97 | 0.43 |
Avg | -1.32 | -1.26 | -1.14 | -1.11 | -0.14 |
Low | -1.42 | -1.45 | -1.18 | -1.25 | -1.07 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.